At BIO KOREA 2025 held at COEX, Seoul, CALICI participated as both a booth exhibitor and panelist, highlighting innovations in AI-based toxicity prediction and alternative testing methods that reduce reliance on animal experiments.

CEO Jaemoon Choi emphasized the importance of predictive reliability, transparency, and regulatory compliance when applying AI to life-critical toxicity assessments. He also noted that generative AI carries potential errors, such as hallucinations, which must be addressed during early model design to ensure safety and standardization.

The event underscored how CALICI and other leading companies are actively responding to global trends in the animal alternative testing market, highlighting not only technological capabilities but also the importance of regulatory frameworks and collaborative ecosystems.